These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30630775)

  • 41. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
    Nemes E; Geldenhuys H; Rozot V; Rutkowski KT; Ratangee F; Bilek N; Mabwe S; Makhethe L; Erasmus M; Toefy A; Mulenga H; Hanekom WA; Self SG; Bekker LG; Ryall R; Gurunathan S; DiazGranados CA; Andersen P; Kromann I; Evans T; Ellis RD; Landry B; Hokey DA; Hopkins R; Ginsberg AM; Scriba TJ; Hatherill M;
    N Engl J Med; 2018 Jul; 379(2):138-149. PubMed ID: 29996082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine.
    Fu H; Lewnard JA; Frost I; Laxminarayan R; Arinaminpathy N
    Nat Commun; 2021 Jan; 12(1):424. PubMed ID: 33462224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses.
    Kagina BM; Tameris MD; Geldenhuys H; Hatherill M; Abel B; Hussey GD; Scriba TJ; Mahomed H; Sadoff JC; Hanekom WA; ; Mansoor N; Hughes J; de Kock M; Whatney W; Africa H; Krohn C; Veldsman A; Kany AL; Douoguih M; Pau MG; Hendriks J; McClainc B; Benko J; Snowden MA; Hokey DA
    Vaccine; 2014 Oct; 32(45):5908-17. PubMed ID: 25218194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bridging the gap between efficacy trials and model-based impact evaluation for new tuberculosis vaccines.
    Tovar M; Arregui S; Marinova D; Martín C; Sanz J; Moreno Y
    Nat Commun; 2019 Nov; 10(1):5457. PubMed ID: 31784512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.
    Talbird SE; Graham J; Mauskopf J; Masseria C; Krishnarajah G
    J Manag Care Spec Pharm; 2015 Jan; 21(1):88-99, 99a-c. PubMed ID: 25562776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.
    Clark RA; Portnoy A; Weerasuriya CK; Sumner T; Bakker R; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
    medRxiv; 2023 Sep; ():. PubMed ID: 37808744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase 2b Controlled Trial of M72/AS01
    Van Der Meeren O; Hatherill M; Nduba V; Wilkinson RJ; Muyoyeta M; Van Brakel E; Ayles HM; Henostroza G; Thienemann F; Scriba TJ; Diacon A; Blatner GL; Demoitié MA; Tameris M; Malahleha M; Innes JC; Hellström E; Martinson N; Singh T; Akite EJ; Khatoon Azam A; Bollaerts A; Ginsberg AM; Evans TG; Gillard P; Tait DR
    N Engl J Med; 2018 Oct; 379(17):1621-1634. PubMed ID: 30280651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Final Analysis of a Trial of M72/AS01
    Tait DR; Hatherill M; Van Der Meeren O; Ginsberg AM; Van Brakel E; Salaun B; Scriba TJ; Akite EJ; Ayles HM; Bollaerts A; Demoitié MA; Diacon A; Evans TG; Gillard P; Hellström E; Innes JC; Lempicki M; Malahleha M; Martinson N; Mesia Vela D; Muyoyeta M; Nduba V; Pascal TG; Tameris M; Thienemann F; Wilkinson RJ; Roman F
    N Engl J Med; 2019 Dec; 381(25):2429-2439. PubMed ID: 31661198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of routine adolescent vaccination with an M72/AS01
    Harris RC; Quaife M; Weerasuriya C; Gomez GB; Sumner T; Bozzani F; White RG
    Nat Commun; 2022 Feb; 13(1):602. PubMed ID: 35105879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tuberculosis vaccines and prevention of infection.
    Hawn TR; Day TA; Scriba TJ; Hatherill M; Hanekom WA; Evans TG; Churchyard GJ; Kublin JG; Bekker LG; Self SG
    Microbiol Mol Biol Rev; 2014 Dec; 78(4):650-71. PubMed ID: 25428938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial.
    Penn-Nicholson A; Tameris M; Smit E; Day TA; Musvosvi M; Jayashankar L; Vergara J; Mabwe S; Bilek N; Geldenhuys H; Luabeya AK; Ellis R; Ginsberg AM; Hanekom WA; Reed SG; Coler RN; Scriba TJ; Hatherill M;
    Lancet Respir Med; 2018 Apr; 6(4):287-298. PubMed ID: 29595510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: Conference proceedings: National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA, November 7, 2014.
    Vaccine Prevention of Sustained Mycobacterium tuberculosis Infection Summary Group
    Vaccine; 2015 Jun; 33(26):3056-64. PubMed ID: 25869889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.
    Martinez L; Cords O; Liu Q; Acuna-Villaorduna C; Bonnet M; Fox GJ; Carvalho ACC; Chan PC; Croda J; Hill PC; Lopez-Varela E; Donkor S; Fielding K; Graham SM; Espinal MA; Kampmann B; Reingold A; Huerga H; Villalba JA; Grandjean L; Sotgiu G; Egere U; Singh S; Zhu L; Lienhardt C; Denholm JT; Seddon JA; Whalen CC; García-Basteiro AL; Triasih R; Chen C; Singh J; Huang LM; Sharma S; Hannoun D; Del Corral H; Mandalakas AM; Malone LL; Ling DL; Kritski A; Stein CM; Vashishtha R; Boulahbal F; Fang CT; Boom WH; Netto EM; Lemos AC; Hesseling AC; Kay A; Jones-López EC; Horsburgh CR; Lange C; Andrews JR
    Lancet Glob Health; 2022 Sep; 10(9):e1307-e1316. PubMed ID: 35961354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.
    Andrews JR; Nemes E; Tameris M; Landry BS; Mahomed H; McClain JB; Fletcher HA; Hanekom WA; Wood R; McShane H; Scriba TJ; Hatherill M
    Lancet Respir Med; 2017 Apr; 5(4):282-290. PubMed ID: 28215501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling.
    Knight GM; McQuaid CF; Dodd PJ; Houben RMGJ
    Lancet Infect Dis; 2019 Aug; 19(8):903-912. PubMed ID: 31281059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
    Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
    Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
    Tameris MD; Hatherill M; Landry BS; Scriba TJ; Snowden MA; Lockhart S; Shea JE; McClain JB; Hussey GD; Hanekom WA; Mahomed H; McShane H;
    Lancet; 2013 Mar; 381(9871):1021-8. PubMed ID: 23391465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.